Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 73 of 297
- RecruitingPhase 1/Phase 2
Opt-IVF for Personalized Medicine for Normal Responders
Urmila DIwekar
- Location
- West Palm Beach, FL
- Eligibility basics
- Ages 20–50 · Women only
- RecruitingPhase 3
A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Hoffmann-La Roche
- Location
- Denver, CO
- Eligibility basics
- Ages 2–11
- RecruitingPhase 4
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Vanda Pharmaceuticals
- Location
- Dothan, AL + 9 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 2
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
Akebia Therapeutics
- Location
- Hollywood, FL + 2 other US sites
- Eligibility basics
- Ages 16+
- RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Celgene
- Location
- Birmingham, AL + 13 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Supernus Pharmaceuticals, Inc.
- Location
- Phoenix, AZ + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Tyra Biosciences, Inc
- Location
- Torrance, CA + 11 other US sites
- Eligibility basics
- Ages 3–10
- RecruitingPhase 2
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
LEO Pharma
- Location
- Fountain Valley, CA + 6 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Nitinotes Surgical Ltd.
- Location
- Los Angeles, CA + 3 other US sites
- Eligibility basics
- Ages 21–65
- RecruitingPhase 1
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Rocket Pharmaceuticals Inc.
- Location
- San Diego, CA + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Regeneron Pharmaceuticals
- Location
- Phoenix, AZ + 9 other US sites
- Eligibility basics
- Ages 18–40 · Women only
- RecruitingPhase 2
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Akebia Therapeutics
- Location
- Chula Vista, CA + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)
Jiangsu HengRui Medicine Co., Ltd.
- Location
- Los Alamitos, CA + 7 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
BioLab Holdings
- Location
- Philidelphia, PA
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
Aimmune Nestlé Health Science US R&D, LLC
- Location
- Lenexa, KS + 1 other US site
- Eligibility basics
- Ages 18–85
- Recruiting
MBA Early Feasibility Study
W.L.Gore & Associates
- Location
- Los Angeles, CA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Janssen Research & Development, LLC
- Location
- Bryant, AR + 33 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Takeda
- Location
- Coral Springs, FL + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
Prime Medicine, Inc.
- Location
- San Antonio, TX
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
Amgen
- Location
- Los Angeles, CA + 3 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 1
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
EpiDestiny, Inc.
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Shockwave Medical, Inc.
- Location
- Phoenix, AZ + 66 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
GlaxoSmithKline
- Location
- Birmingham, AL + 18 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
AstraZeneca
- Location
- Phoenix, AZ + 18 other US sites
- Eligibility basics
- Ages 5–17
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies